These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 1382937

  • 21. [Pharmacokinetic and clinical evaluations of imipenem/cilastatin sodium in neonates and premature infants].
    Motohiro T, Sakata Y, Oda K, Kawakami A, Tanaka K, Koga T, Shimada Y, Tomita S, Fujimoto T, Tominaga K.
    Jpn J Antibiot; 1989 May; 42(5):1102-24. PubMed ID: 2664254
    [Abstract] [Full Text] [Related]

  • 22. Beneficial herb-drug interaction of rhein in Jinhongtang and Imipenem/Cilastatin mediated by organic anion transporters.
    Wu F, Zhao T, Zhang Y, Wang Y, Liao G, Zhang B, Wang C, Tian X, Feng L, Fang B, Huo X, Ma X.
    J Ethnopharmacol; 2023 Aug 10; 312():116449. PubMed ID: 37023835
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [A randomized, controlled clinical trial of meropenem and imipenem/cilastatin in the treatment of acute bacterial infections].
    Hou F, Wu G, Zheng B.
    Zhonghua Nei Ke Za Zhi; 2001 Sep 10; 40(9):589-93. PubMed ID: 11758237
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia.
    Freire AT, Melnyk V, Kim MJ, Datsenko O, Dzyublik O, Glumcher F, Chuang YC, Maroko RT, Dukart G, Cooper CA, Korth-Bradley JM, Dartois N, Gandjini H, 311 Study Group.
    Diagn Microbiol Infect Dis; 2010 Oct 10; 68(2):140-51. PubMed ID: 20846586
    [Abstract] [Full Text] [Related]

  • 28. Evaluating imipenem + cilastatin + relebactam for the treatment of complicated urinary tract infections.
    Kuiper SG, Leegwater E, Wilms EB, van Nieuwkoop C.
    Expert Opin Pharmacother; 2020 Oct 10; 21(15):1805-1811. PubMed ID: 32820669
    [Abstract] [Full Text] [Related]

  • 29. Monotherapy in serious hospital-acquired infections: a clinical trial of ceftazidime versus imipenem/cilastatin. European Study Group.
    Norrby SR, Finch RG, Glauser M.
    J Antimicrob Chemother; 1993 Jun 10; 31(6):927-37. PubMed ID: 8360130
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Meropenem: evaluation of a new generation carbapenem.
    Blumer JL.
    Int J Antimicrob Agents; 1997 Mar 10; 8(2):73-92. PubMed ID: 18611786
    [Abstract] [Full Text] [Related]

  • 35. Intramuscular imipenem/cilastatin in the treatment of mild and moderate infections.
    Wang C, Pappas F, Cook T.
    Scand J Infect Dis Suppl; 1987 Mar 10; 52():32-9. PubMed ID: 3331041
    [Abstract] [Full Text] [Related]

  • 36. Meropenem versus imipenem/cilastatin in the treatment of sepsis in Chinese patients.
    Kuo BI, Fung CP, Liu CY.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 May 10; 63(5):361-7. PubMed ID: 10862445
    [Abstract] [Full Text] [Related]

  • 37. [Clinical pharmacokinetics of an imipenem-cilastatin combination].
    Singlas E.
    Presse Med; 1990 Apr 04; 19(13):598-605. PubMed ID: 2139939
    [Abstract] [Full Text] [Related]

  • 38. [Effectiveness of imipenem/cilastatin (Tienam, MSD) in treating complicated infections in urology].
    Derevianko II, Nefedova LA, Lavrinova LN.
    Urologiia; 2002 Apr 04; (3):21-5. PubMed ID: 12180053
    [Abstract] [Full Text] [Related]

  • 39. Ceftriaxone versus imipenem/cilastatin as empirical monotherapy for infections in cancer patients.
    Bucaneve G, Menichetti F, Minotti V, Pasticci MB, Tonato M, Del Favero A.
    Chemotherapy; 1989 Apr 04; 35 Suppl 2():10-5. PubMed ID: 2612235
    [Abstract] [Full Text] [Related]

  • 40. Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study.
    Sanz MA, Bermúdez A, Rovira M, Besalduch J, Pascual MJ, Nocea G, Sanz-Rodríguez C, COSTINE Study Group.
    Curr Med Res Opin; 2005 May 04; 21(5):645-55. PubMed ID: 15969864
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.